129 related articles for article (PubMed ID: 29329678)
1. Apelin-13 ameliorates cognitive impairments in 6-hydroxydopamine-induced substantia nigra lesion in rats.
Haghparast E; Esmaeili-Mahani S; Abbasnejad M; Sheibani V
Neuropeptides; 2018 Apr; 68():28-35. PubMed ID: 29329678
[TBL] [Abstract][Full Text] [Related]
2. Neurosteroid allopregnanolone attenuates cognitive dysfunctions in 6-OHDA-induced rat model of Parkinson's disease.
Nezhadi A; Sheibani V; Esmaeilpour K; Shabani M; Esmaeili-Mahani S
Behav Brain Res; 2016 May; 305():258-64. PubMed ID: 26970579
[TBL] [Abstract][Full Text] [Related]
3. Apelin-13 prevents hippocampal synaptic plasticity impairment in Parkinsonism rats.
Esmaeili-Mahani S; Haghparast E; Nezhadi A; Abbasnejad M; Sheibani V
J Chem Neuroanat; 2021 Jan; 111():101884. PubMed ID: 33161074
[TBL] [Abstract][Full Text] [Related]
4. Apelin-13 attenuates motor impairments and prevents the changes in synaptic plasticity-related molecules in the striatum of Parkinsonism rats.
Haghparast E; Sheibani V; Abbasnejad M; Esmaeili-Mahani S
Peptides; 2019 Jul; 117():170091. PubMed ID: 31121196
[TBL] [Abstract][Full Text] [Related]
5. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
[TBL] [Abstract][Full Text] [Related]
6. Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats.
Matheus FC; Rial D; Real JI; Lemos C; Ben J; Guaita GO; Pita IR; Sequeira AC; Pereira FC; Walz R; Takahashi RN; Bertoglio LJ; Da Cunha C; Cunha RA; Prediger RD
Behav Brain Res; 2016 Mar; 301():43-54. PubMed ID: 26707254
[TBL] [Abstract][Full Text] [Related]
7. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
Kopalli SR; Noh SJ; Koppula S; Suh YH
Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
[TBL] [Abstract][Full Text] [Related]
8. Curcumin improves neurofunctions of 6-OHDA-induced parkinsonian rats.
Song S; Nie Q; Li Z; Du G
Pathol Res Pract; 2016 Apr; 212(4):247-51. PubMed ID: 26922613
[TBL] [Abstract][Full Text] [Related]
9. Nitrosative and cognitive effects of chronic L-DOPA administration in rats with intra-nigral 6-OHDA lesion.
Ramírez-García G; Palafox-Sánchez V; Limón ID
Neuroscience; 2015 Apr; 290():492-508. PubMed ID: 25644418
[TBL] [Abstract][Full Text] [Related]
10. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulphide attenuates neuronal apoptosis of substantia nigra by re-establishing autophagic flux via promoting leptin signalling in a 6-hydroxydopamine rat model of Parkinson's disease.
Jiang W; Zou W; Hu M; Tian Q; Xiao F; Li M; Zhang P; Chen YJ; Jiang JM
Clin Exp Pharmacol Physiol; 2022 Jan; 49(1):122-133. PubMed ID: 34494284
[TBL] [Abstract][Full Text] [Related]
12. Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?
Herrera ML; Deza-Ponzio R; Ghersi MS; de la Villarmois EA; Virgolini MB; Pérez MF; Molina VA; Bellini MJ; Hereñú CB
ASN Neuro; 2020; 12():1759091420925977. PubMed ID: 32466659
[TBL] [Abstract][Full Text] [Related]
13. Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations.
Ferro MM; Bellissimo MI; Anselmo-Franci JA; Angellucci ME; Canteras NS; Da Cunha C
J Neurosci Methods; 2005 Oct; 148(1):78-87. PubMed ID: 15939479
[TBL] [Abstract][Full Text] [Related]
14. Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson's disease through Akt/GSK3β signaling pathway.
Yang L; Zhang X; Li S; Wang H; Zhang X; Liu L; Xie A
Life Sci; 2020 Oct; 259():118159. PubMed ID: 32763288
[TBL] [Abstract][Full Text] [Related]
15. The effects of short-term nicotine administration on behavioral and oxidative stress deficiencies induced in a rat model of Parkinson's disease.
Ciobica A; Padurariu M; Hritcu L
Psychiatr Danub; 2012 Jun; 24(2):194-205. PubMed ID: 22706419
[TBL] [Abstract][Full Text] [Related]
16. 7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson's disease.
Haik KL; Shear DA; Hargrove C; Patton J; Mazei-Robison M; Sandstrom MI; Dunbar GL
Exp Clin Psychopharmacol; 2008 Apr; 16(2):178-89. PubMed ID: 18489022
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective action and mechanistic evaluation of protodioscin against rat model of Parkinson's disease.
Wu J; Zhao YM; Deng ZK
Pharmacol Rep; 2018 Feb; 70(1):139-145. PubMed ID: 29367101
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
20. Ineffectiveness of saxagliptin as a neuroprotective drug in 6-OHDA-lesioned rats.
Turnes JM; Bassani TB; Souza LC; Vital MABF
J Pharm Pharmacol; 2018 Aug; 70(8):1059-1068. PubMed ID: 29766510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
